NHS National Pharmaceuticals - Everolimus and terminated agreement products
key details
| Value | £4,516,089 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber |
| Deadline | 26 Apr 2021 |
| Contract start | 15 May 2021 |
| Contract end | 1 Mar 2022 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-51020b45-d75d-4130-b087-2ad6af1d1e05 |
Awards (15)
This procurement was awarded to 15 suppliers. Values shown are per-award; the notice total is £4,516,089.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £4,516,089 | 7 Jun 2021 | active |
| Bowmed Ibisqus Limited shared | £4,516,089 | 7 Jun 2021 | active |
| Bristol Laboratories Limited shared | £4,516,089 | 7 Jun 2021 | active |
| Crescent Pharma Ltd shared | £4,516,089 | 7 Jun 2021 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £4,516,089 | 7 Jun 2021 | active |
| Drugsrus Ltd shared | £4,516,089 | 7 Jun 2021 | active |
| Fresenius Kabi Limited shared | £4,516,089 | 7 Jun 2021 | active |
| Martindale Pharma shared | £4,516,089 | 7 Jun 2021 | active |
| Medreich PLC shared | £4,516,089 | 7 Jun 2021 | active |
| Milpharm Ltd/aurobinbdo shared | £4,516,089 | 7 Jun 2021 | active |
| Mylan shared | £4,516,089 | 7 Jun 2021 | active |
| Ranbaxy UK shared | £4,516,089 | 7 Jun 2021 | active |
| Selective Supplies Ltd. shared | £4,516,089 | 7 Jun 2021 | active |
| Teva UK Limited shared | £4,516,089 | 7 Jun 2021 | active |
| Torrent Pharma UK Ltd shared | £4,516,089 | 7 Jun 2021 | active |
description
Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement products
Offer reference number: CM/PHG/21/5632
Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Potential periods of call-offs under the framework agreement:
Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022
Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022
Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022
documents
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLka/Q9R6UvHRLYxSRiKFFoAKGgv8t_vUHLtnAcPXCosQUlk , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkb/d.hnrkbP90kLLalIRykdP9rRZ7r1wNiRi_UosE9Phs4 , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkf/aa.c0jLqkn7Jkm2Clt0rNVWe91LIVvPrm95J2v_0AUA , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkg/khmtJiVSTjD9NfUPJBstfaF5ssV_PbrLx7lO7AGEhjo , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkh/N.ngD0FFcr2_.8o6ydbAPU5pjmYH6u_CDWslqNCp7fQ , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkk/AqnLTNbSiXBuPLMNF1RmF2uUA6BMxQWjqjUtiz.IOz0 , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkl/OpfXYhW0hFEHSZNuvsKHP1Y2PKDRvT03X3uYVa8fXgI , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkm/qbdByrJNHur91cEbIjwAwKkHpNPKQJVhtgfrMAfkXfs , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkn/3Uqdn9uozzwdz77pQ9x6MbwYJ3O8ShE0yzFY25K2N.M , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLko/vFBvJs87O6C6bId1CEx6Y8xIErG7bfdqJChOdiUF8bA , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkp/ah6w_KrHQyhJsXTkdfzKJLkE556DYVR.BCeHDSyYunA , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLku/NXDYgLz3iwb6gBxsCBRIqaMwN7TMtKDER0Xr9t1BOaE , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkz/df3zKmJ7mlf7AJof3o7ejJTpthwxvNpq8CoSxJrfMps , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLl4/oLiz.eGY8KAak1HgYLIbVEIVH80KPHZyfyIT1EzbJmo , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLl5/4C4KS_U1lHnBEKe8mIa20v3AOvNKEiuEgJGeTXr8A.s , Link
- https://www.contractsfinder.service.gov.uk/Notice/b7aad1a9-5aca-40f3-a4d7-5c1e65f5be1b , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 9 Apr 2021 | Tender (tender) | · | b7aad1a9-5aca-40f3-a4d7-5c1e65f5be1b-427538 |
| 20 Oct 2021 | Award (award) | · | d8bd8537-518f-4efd-b223-ff9c32f18a87-478360 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.